Hims & Hers Health (HIMS) Research & Development (2021 - 2026)

Hims & Hers Health has disclosed Research & Development across 6 years of filings, most recently posting $46.9 million for Q1 2026.

• Research & Development for Q1 2026 came in at $46.9 million, up 56.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $166.3 million (up 78.06% YoY), and the FY2025 annual result was $149.3 million, up 89.42% from the prior year.
• Research & Development came in at $46.9 million for Q1 2026 at Hims & Hers Health, up from $41.0 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $46.9 million in Q1 2026 to a low of $6.1 million in Q1 2022.
• The 5-year median for Research & Development is $15.3 million (2024), against an average of $20.7 million.
• Across the five-year window, Research & Development grew 27.8% in 2022 and soared 102.89% in 2025, its largest moves.
• Hims & Hers Health's Research & Development stood at $8.3 million in 2022, then jumped by 61.29% to $13.4 million in 2023, then surged by 77.17% to $23.7 million in 2024, then surged by 72.48% to $41.0 million in 2025, then advanced by 14.58% to $46.9 million in 2026.
• The last three Research & Development figures came in at $46.9 million (Q1 2026), $41.0 million (Q4 2025), and $40.6 million (Q3 2025), per Business Quant data.